Erratum: Radial artery pseudoaneurysm: A rare complication with serious risk to life and limb (Anesthesiology (2013) 118 (188) DOI: 10.1097/ALN.0b013e318279f925);CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population

Anesthesiology

Volumn 118, Issue 2, 2013, Pages 344-349

  Kraeva, Natalia ^a   Zvaritch, Elena ^b   Frodis, Wanda ^a   Sizova, Olga ^b   Kraev, Alexander ^b   MacLennan, David H ^b   Riazi, Sheila ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTININ; CAFFEINE; CALSEQUESTRIN; DESMIN; HALOTHANE; MEMBRANE PROTEIN; PROTEIN CASQ1; TUBULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GRACILIS MUSCLE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 84872920344     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001265     Document Type: Erratum

References (34)

1. Britt BA, Kalow W: Malignant hyperthermia: Aetiology unknown. Can Anaesth Soc J 1970; 17:316-30
2. Rosenberg H, Davis M, James D, Pollock N, Stowell K: Malignant hyperthermia. Orphanet J Rare Dis 2007; 2:21
3. MacLennan DH, Zvaritch E: Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta 2011; 1813:948-64
4. Allen GC, Larach MG, Kunselman AR: The sensitivity and specificity of the caffeine-halothane contracture test: A report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology 1998; 88:579-88
5. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG: Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990; 343:559-61
6. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P: Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27:977-89
7. Rosenberg H, Rueffert H: Clinical utility gene card for: Malignant hyperthermia. Eur J Hum Genet 2011; 19:
8. Dainese M, Quarta M, Lyfenko AD, Paolini C, Canato M, Reggiani C, Dirksen RT, Protasi F: Anesthetic-and heatinduced sudden death in calsequestrin-1- knockout mice. FASEB J 2009; 23:1710-20
9. Protasi F, Paolini C, Dainese M: Calsequestrin-1: A new candidate gene for malignant hyperthermia and exertional/environmental heat stroke. J Physiol (Lond) 2009; 587(Pt 13):3095-100
10. MacLennan DH, Chen SR: Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. J Physiol (Lond) 2009; 587(Pt 13):3113-5
11. Larach MG: Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69:511-5
12. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ørding H, Rosenberg H, Waud BE, Wedel D: A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771-9
13. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9
14. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215
15. Kraev N, Loke JC, Kraev A, MacLennan DH: Protocol for the sequence analysis of ryanodine receptor subtype 1 gene transcripts from human leukocytes. Anesthesiology 2003; 99:289-96
16. Monnier N, Procaccio V, Stieglitz P, Lunardi J: Malignanthyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997; 60:1316-25
17. Toppin PJ, Chandy TT, Ghanekar A, Kraeva N, Beattie WS, Riazi S: A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene. Can J Anaesth 2010; 57:689-93
18. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 2010; 7:248-9
19. Kumar P, Henikoff S, Ng PC: Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4:1073-81
20. Ferrer-Costa C, Orozco M, de la Cruz X: Sequence-based prediction of pathological mutations. Proteins 2004; 57:811-9
21. Simpson IA, Sonne O: A simple, rapid, and sensitive method for measuring protein concentration in subcellular membrane fractions prepared by sucrose density ultracentrifugation. Anal Biochem 1982; 119:424-7
22. Sasieni PD: From genotypes to genes: Doubling the sample size. Biometrics 1997; 53:1253-61
23. Park H, Park IY, Kim E, Youn B, Fields K, Dunker AK, Kang C: Comparing skeletal and cardiac calsequestrin structures and their calcium binding: A proposed mechanism for coupled calcium binding and protein polymerization. J Biol Chem 2004; 279:18026-33
24. Priori SG, Chen SR: Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res 2011; 108:871-83
25. Sato Y, Ferguson DG, Sako H, Dorn GW II, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG: Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 1998; 273:28470-7
26. Beard NA, Laver DR, Dulhunty AF: Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 2004; 85:33-69
27. Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC: Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 2004; 53:3300-6
28. Wang S, Trumble WR, Liao H, Wesson CR, Dunker AK, Kang CH: Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 1998; 5:476-83
29. Kim E, Youn B, Kemper L, Campbell C, Milting H, Varsanyi M, Kang C: Characterization of human cardiac calsequestrin and its deleterious mutants. J Mol Biol 2007; 373:1047-57
30. Jeltsch A: Epigenetics Europe conference. Munich, Germany, 8-9 September 2011. Epigenomics 2011; 3:693-5
31. Rodenhiser DI, Bérubé NG, Mann MR: Epigenetics, eh! A meeting summary of the Canadian Conference on Epigenetics. Epigenetics 2011; 6:1265-71
32. Sanchez EJ, Munske GR, Criswell A, Milting H, Dunker AK, Kang C: Phosphorylation of human calsequestrin: implications for calcium regulation. Mol Cell Biochem 2011; 353:195-204
33. Kirchhefer U, Wehrmeister D, Postma AV, Pohlentz G, Mormann M, Kucerova D, Müller FU, Schmitz W, Schulze-Bahr E, Wilde AA, Neumann J: The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. J Mol Cell Cardiol 2010; 49:95-105
34. Sanchez EJ, Lewis KM, Munske GR, Nissen MS, Kang C: Glycosylation of skeletal calsequestrin: Implications for its function. J Biol Chem 2012; 287:3042-50